معرفی
Dr. Sarah Dimeloe is an Associate Professor at the University of Birmingham, affiliated with the Department of Immunology and Immunotherapy and the Department of Metabolism and Systems Science within the College of Medicine and Health. Her research focuses on immune cell metabolism, with particular emphasis on its role in health, autoimmune diseases, and cancer, including multiple myeloma and rheumatoid arthritis.
Education: PhD in Immunology (King’s College London, 2012), MSc Immunology (King’s College London), and MPharm Pharmacy (University of Nottingham, 2004). Postdoctoral research (2012–2017) at the University of Basel under Prof. Christoph Hess. Established her independent lab at the University of Birmingham in 2017 via a Birmingham Fellowship.
Research Interests: Metabolic regulation of immune cell function in disease contexts, including the bone marrow microenvironment’s impact in multiple myeloma, T cell metabolic reprogramming in rheumatoid arthritis, and the role of metabolic cofactors like NAD. Current projects investigate cytokine-driven metabolic pathways and tumor-immune interactions.
Awards/Grants: Lister Institute Prize Fellowship (2024), Leukemia UK John Goldman Fellowship, MRC New Investigator Research Grant, and European Commission Marie Curie Actions Fellowship. Active on the Wellcome Trust Career Development Award interview panel.
Advising/Teams: Supervises 2 PhD students and 1 MSc student. Collaborates on projects funded by Blood Cancer UK and the European Union. Lab activities include multiomics analysis of metabolic pathways and translational studies on immunotherapy targets.
